News & Announcements

Research Tools for Psychoactive Mushroom Components & Their Metabolites

Article from 2023-07-06


By Danielle St. Germaine, Forensic Chemistry Division, Cayman Chemical

Mushrooms have been used in medicinal and spiritual practices in Indigenous cultures around the world for several millennia. A wide variety of species of gilled mushrooms under the order of Agaricales contain psychoactive alkaloids. The two most studied genera include Psilocybe and Amanita. Because of renewed interest in entheogenic plant molecules as therapeutics, there is a large body of research building around the psychedelic effects of alkaloids found in these mushrooms.

magic-molecules-poster.png

Download or Request a Lab Wall Poster

Psilocybe Mushrooms

Psilocybe mushrooms produce tryptamine and β-carboline alkaloids that elicit their hallucinogenic effects by acting upon serotonin (5-HT) receptors.1 Psilocin is currently the most studied tryptamine alkaloid; however, studies show others may also contribute to 5-HT2A activity.2

psilocybe figure 01

Figure 1. Summary of Psilocybe mushrooms.


Tryptamine Analytical Standards Panel

Tryptamine Analytical Standards Panel

Contains 64 analytical reference materials and standards categorized as tryptamines and tryptamine metabolites.



Biosynthetic Pathway of Psilocybe

The biosynthetic pathway of psilocybin has been elucidated from the amino acid tryptophan.3,4 Tryptophan is decarboxylated by L-tryptophan decarboxylase (PsiD) to form tryptamine, which is then oxidized by indole 4-monooxygenase (PsiH) to 4-hydroxytryptamine. 4-Hydroxytryptamine is then phosphorylated by a kinase (PsiK) to form norbaeocystin, which is then methylated by N-methyltransferase (PsiM) to form baeocystin (monomethylation) and psilocybin (dimethylation). A third methylation to form aeruginascin, previously thought to only occur in Inocybe species, was observed for the first time in Psilocybe cubensis in 2020. There is also a shunt pathway that was observed where 4-hydroxytryptamine is methylated to form norpsilocin.4

Figure 2. The biosynthetic pathway of psilocybin and related alkaloids in Psilocybe mushrooms. Dashed arrows indicate hypothesized protective mechanism.


Mushroom Phosphorylated Tryptamine Mixture (CRM)

Contains psilocybin, aeruginascin, baeocystin, norbaeocystin

 

Psilocybe Components

Item No.

Aeruginascin 31582 | 37762 (CRM)
Psilocybin 14041 | 9003134 (CRM)
Baeocystin 31583 | 37763 (CRM)
Norbaeocystin 31584 | 37764 (CRM)
4-hydroxy TMT (iodide) 33670 | 38032 (CRM)
Psilocin 11864 | 9003135 (CRM)
Norpsilocin 23586 | 37943 (CRM)
4-hydroxytryptamine (fumarate) 9002547 | 38031 (CRM)
Tryptamine 33682
L-Tryptophan 29600


Deuterated versions of many Psilocybe mushroom components are available from Cayman. 

Deuterated Psilocybe Components

Item No.

Aeruginascin-d3 37124
Psilocybin-d4
33760 | 35092 (CRM)
Psilocybin-d6 34608
Psilocybin-d10 33761
Baeocystin-d4 37125
Psilocin-d6 34780
Psilocin-d10 31734 | 37038 (CRM)
Norpsilocin-d4 37127
Tryptamine-d4 (hydrochloride) 33538

Psilocybin is dephosphorylated by phosphatase (PsiP) to psilocin. Rapid oxidation of psilocin then forms oligomeric structures that contribute to the bluing that occurs in freshly cut and aging fruiting bodies.5-7 The 7,7'-didehydrodimer of psilocin appears to be the primary contributor to the blue chromophore.7 The oligomeric structures are hypothesized to be a defense mechanism against pests and predators.4 It has been demonstrated that PsiK is able to re-phosphorylate psilocin to psilocybin. This process is thought to be a protective mechanism to repair the cell from the liberation of phenolic tryptamines.


Figure 3. Oxidation of psilocin and norpsilocin produces the blue color observed in Psilocybe mushrooms. 

 

Human Metabolism of Psilocybin

Psilocybin is metabolized to the psychoactive metabolite psilocin. Psilocin is then metabolized by monoamine oxidase (MAO) and presumably aldehyde dehydrogenase (ALDH) to 4-hydroxyindole-3-acetic acid (4-HIAA) and 4-hydroxytryptophole. Phase II metabolism by glucuronosyltransferase (UGT) results in the major metabolite psilocin-O-glucuronide.1 Minor oxidation pathways have also been described.

Figure 4. Human metabolism of psilocybin to the psychoactive compound psilocin and downstream metabolites.

Psilocybin Metabolites

Item No.

Psilocin 11864 | 9003135 (CRM)
4-Hydroxyindole-3-acetic Acid
33632


Cayman continually introduces new CRMs and analytical standards as the research evolves.

β-Carboline Alkaloids

β-Carboline alkaloids in Psilocybe mushrooms are also biologically active. Several act as monoamine oxidase inhibitors (MAOIs), which potentiate the psychedelic effects of the tryptamine alkaloids by inhibiting their metabolism.8

Figure 5. Structures of known β-carboline alkaloids in Psilocybe mushrooms.

β-Carboline Alkaloids Mixture

Contains harmane, norharmane, harmol, harmine, and cordysinin C/D. 


β-Carboline Alkaloids

Item No.

Harmane 33843
Norharmane 33845
Harmol
33844
Harmine 35146
Tetrahydroharmine 35037
Cordysinin C/D 38207


Amanita muscaria Mushrooms

Amanita mushrooms are often portrayed as the icon of psychedelic mushrooms in media and pop culture with their characteristic vivid red and white spotted toadstool. However, their active alkaloids are ibotenic acid and muscimol which act upon a distinctly different set of neurotransmitters than their Psilocybe counterparts.1,2,9,10

Figure 6. Summary of Amanita mushrooms. 

Amanita muscaria Components

Item No.

Ibotenic Acid 38029
Muscimol 38030

 

Mushroom Toxins

Misidentification of mushrooms can lead to severe poisoning and death. Muscarine, a potent cholinergic receptor agonist, can be found in A. muscaria as well as certain psilocybin-containing species such as Inocybe.11 Certain species of Amanita contain deadly cyclopeptide toxins (amatoxins and phallotoxins) that cause hepatic and renal failure.12A. bisporigera (also known as Destroying Angel) and A. pholloides (also known as Deathcap) are responsible for most fatal mushroom poisonings worldwide.13 Their toxicity stems from a lack of medical intervention strategies, however, researchers have recently discovered that indocyanine green could act as a possible antidote.14

Amanita Toxins

Item No.

β-Amanitin 18142
α-Amanitin 17898
Phallacidin 18146
Phalloidin 18039
(+)-Muscarine (tosylate) 38853

Cayman offers a comprehensive portfolio of products including ISO Certified Reference Materials (CRMs) for Psilocybe and Amanita mushroom components and their metabolites. Cayman will continue to frequently add new products and CRMs to help make your research possible.

Don't see what you're looking for? Contact our sales department for inquiries at sales@caymanchem.com.



You May Also Be Interested In


The Magic and Chemistry Behind Psychedelic Mushrooms
The Magic and Chemistry Behind Psychedelic Mushrooms
Psychedelic Drug Discovery
Psychedelic Drug Discovery

Rediscovering Psilocybin and Its Therapeutic Potential
Rediscovering Psilocybin and Its Therapeutic Potential

Forensic Lab Guide Wall Posters
Forensic Lab Guide Wall Posters




References


1. Dinis-Oliveira, R.J. Metabolism of psilocybin and psilocin: Clinical and forensic toxicological relevance. Drug Metab. Rev. 49(1), 84-91 (2017).

2. Glatfelter, G.C., Pottie, E., Partilla, J.S. et al. Structure–activity relationships for psilocybin, baeocystin, aeruginascin, and related analogues to produce pharmacological effects in mice. ACS Pharmacol. Transl. Sci. 5(11), 1181-1196 (2022).

3. Fricke, J., Blei, F., and Hoffmeister, D. Enzymatic synthesis of psilocybin. Angew. Chem. Int. Ed. Engl. 56(40), 12352-12355 (2017).

4. Lenz, C., Sherwood, A., Kargbo, R., et al. Taking different roads: L-Tryptophan as the origin of Psilocybe natural products. Chempluschem 86(1), 28-35 (2020).

5. Gotvaldová K., Hájková, K., Boroviĉka, J., et al. Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis. Drug Test. Anal. 13(2):439-446 (2021).

6. Lenz, C., Wick, J., Braga, D., et al. Injury-triggered blueing reactions of Psilocybe "magic" mushrooms. Angew. Chem. Int. Ed. Engl.  59(4):1450-1454 (2019).

7. Lenz, C. Dörner, S., Sherwood, A., et al. Structure elucidation and spectroscopic analysis of chromophores produced by oxidative psilocin dimerization. Chemistry Eur. J. 27(47), 12166-12171 (2021).

8. Dörner, S., Rogge, K., Fricke, J., et al. Genetic survey of Psilocybe natural products. Chembiochem 23(14):e202200249 (2022). See also: Blei, F., Dörner, S., Fricke, J., et al. Simultaneous production of psilocybin and a cocktail of β-carboline monoamine oxidase inhibitors in "magic" mushrooms. Chemistry Eur. J. 26(3):729-734 (2020). 

9. Obermaier, S. and Müller, M. Ibotenic acid biosynthesis in the fly agaric is initiated by glutamate hydroxylation. Angew. Chem. Int. Ed. Engl.  59(30):12432-12435 (2020).

10. Voynova, M., Shkondrov, A., Kondeva-Burdina, M., et al. Toxicological and pharmacological profile of Amanita muscaria (L.) Lam. – a new rising opportunity for biomedicine. Pharmacia 67(4):317-323 (2020).   

11. Patocka, J., Wu, R., Nepovimova, E., et al. Chemistry and toxicology of major bioactive substances in Inocybe mushrooms. Int. J Mol. Sci. 22(4), 2218 (2021).

12. Govorushko, S., Rezaee, R., Dumanov, J., et al. Poisoning associated with the use of mushrooms: A review of the global pattern and main characteristics. Food Chem. Toxicol. 128:267-279 (2019).

13. Garcia, J., Costa, V.M., Carvalho, A., et al. Amanita phalloides poisoning: Mechanisms of toxicity and treatment. Food Chem. Toxicol. 86:41-55 (2015).

14. Wang, B., Wan, A.H., Xu, Y. et al. Identification of indocyanine green as a STT3B inhibitor against mushroom α-amanitin cytotoxicity. Nat. Commun. 14(1), 2241 (2023).



Receive Our News & Literature Directly to Your Inbox!

Log in or register to subscribe to our email list. You will receive emails packed with new products and content that match your research interests. We only email once a week and you can unsubscribe at any time.